Not Yet Recruiting A Phase II Randomized Study to Evaluate Measures for Endpoint Derivation in Patients With Progressive or Refractory Disseminated Coccidioidomycosis (DCM ) Treated With Olorofim Plus Baseline SOC or Placebo Plus Baseline SOC NCT07712484 Conditions Bacterial Infections and Mycoses, Coccidioides Immitis Infection, Coccidioides Infection, +9 more Locations Not specified View Trial Details
